REDWOOD CITY, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that two of the ...
AUSTIN, Texas, Dec. 1, 2020 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Orphan Technologies, a company dedicated to helping patients control their homocysteine levels, today announced that OT-58 for the treatment of cystathionine beta ...
HCU is a rare autosomal recessive inherited sulfur amino acid metabolism disorder primarily caused by a cystathionine beta-synthase deficiency (CBS). HCU patients have a broad spectrum of age (older ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Orphan Technologies, a company dedicated to helping patients control their homocysteine levels, published study showing that 12,113 patients in the United States are ...
In a new paper, researchers describe finding the gene that causes Mexican cavefish to lose their vision. The same gene responsible for this evolutionary change in the fish is also responsible for ...
Denovo Sciences Inc, a pioneer in AI-driven drug discovery based on synthetic data, Weill Cornell Medicine-Qatar (WCM-Q), and Sidra Medicine are engaging in a collaboration to identify and develop ...
- Rare metabolic disorder with no adequate treatment options affects an estimated 12,113 patients according to strict ICD-10 diagnostic claims data - Healthcare costs for patients with ICD-10 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback